Serum Institute Of India Pvt. Ltd.

This study tests Cervavac, an HPV vaccine, in women aged 15-25 who are living with HIV. HPV infection can lead to cervical cancer, and women with HIV are at higher risk. The trial compares two-dose and three-dose schedules of Cervavac against a standard vaccine to see how well th…

This Phase 2 trial is testing a malaria vaccine that aims to both prevent infection and block the parasite from spreading to mosquitoes. Around 1,200 healthy participants aged 9 to 50 in Mali will receive either the R21 vaccine alone or a combination with Pfs230D1-CRM197, both wi…